Resapp Health Ltd
ASX:RAP
Relative Value
There is not enough data to reliably calculate the relative value of RAP.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
RAP Competitors Multiples
Resapp Health Ltd Competitors
Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
---|---|---|---|---|---|---|---|---|
AU |
Resapp Health Ltd
ASX:RAP
|
176.2m AUD | 70.1 | -24.8 | -25 | -25 | ||
US |
Veeva Systems Inc
NYSE:VEEV
|
37.6B USD | 15.9 | 71.8 | 72.6 | 78.1 | ||
US |
Cerner Corp
NASDAQ:CERN
|
27.9B USD | 4.8 | 47.3 | 19.6 | 38.6 | ||
JP |
M3 Inc
TSE:2413
|
1.5T JPY | 6.3 | 31.8 | 17.2 | 19.4 | ||
US |
Change Healthcare Inc
NASDAQ:CHNG
|
9B USD | 2.6 | -116.8 | 16.5 | 111.6 | ||
AU |
Pro Medicus Ltd
ASX:PME
|
10.8B AUD | 74.1 | 155.5 | 106.8 | 106.8 | ||
US |
Inspire Medical Systems Inc
NYSE:INSP
|
6.3B USD | 10.3 | -303.3 | -156.3 | -145.3 | ||
US |
Doximity Inc
NYSE:DOCS
|
5B USD | 10.8 | 36.7 | 24.9 | 26.5 | ||
SE |
Sectra AB
STO:SECT B
|
39.8B SEK | 24.3 | 93.7 | -61.6 | -61.6 | ||
US |
Evolent Health Inc
NYSE:EVH
|
3.7B USD | 1.9 | -26.2 | 30.3 | 322.9 | ||
US |
Certara Inc
NASDAQ:CERT
|
2.8B USD | 8.2 | -52.9 | 46.1 | 462.1 |